Skip to main content
Top
Published in: Rheumatology International 8/2018

Open Access 01-08-2018 | Clinical Trial

Reduced anterior cingulate grey matter volume in painful hand osteoarthritis

Authors: Mark D. Russell, Thomas R. Barrick, Franklyn A. Howe, Nidhi Sofat

Published in: Rheumatology International | Issue 8/2018

Login to get access

Abstract

Objective

Increasing evidence supports the role of central sensitisation in osteoarthritis (OA) pain. In this study, we used neuroimaging to compare pain-processing regions of the brain in participants with and without hand OA. We then assessed for volumetric changes in these brain regions following treatment with centrally acting analgesics.

Methods

Participants with hand OA (n = 28) underwent T1-weighted MRI of the brain before and after 12 weeks of treatment with pregabalin, duloxetine or placebo. Grey matter volume in the anterior cingulate cortex (ACC), insular cortex and thalamus was compared to non-OA control subjects (n = 11) using FreeSurfer regional volumetric analysis and voxel-based morphometry, and evaluated for differences pre- and post-treatment.

Results

Relative to non-OA controls, hand OA participants had areas of reduced grey matter volume in the ACC at baseline (p = 0.007). Regional volumetric differences in the ACC persisted after 13 weeks’ treatment with pregabalin or duloxetine (p = 0.004) with no significant differences between treatment cohorts, despite improvements in NRS pain scores for pregabalin (p = 0.005) and duloxetine (p = 0.050). The ACC grey matter changes persisted despite a significant improvement in pain in the pregabalin and duloxetine groups vs. placebo. No structural differences were observed in the insular cortex or thalamus at baseline or following treatment.

Conclusion

Our study found evidence of reduced ACC grey matter volume in participants with hand arthritis that persisted after treatment with centrally acting analgesics pregabalin and duloxetine, respectively. The sustained changes observed in the ACC in our study could reflect the relatively short duration of treatment, or that the differences observed are irreversible volume changes due to chronic pain that are established over time.
Appendix
Available only for authorised users
Literature
1.
go back to reference Smallwood RF, Laird AR, Ramage AE, Parkinson AL, Lewis J, Clauw DJ et al (2013) Structural brain anomalies and chronic pain: a quantitative meta-analysis of grey matter volume. J Pain 14:663–675CrossRef Smallwood RF, Laird AR, Ramage AE, Parkinson AL, Lewis J, Clauw DJ et al (2013) Structural brain anomalies and chronic pain: a quantitative meta-analysis of grey matter volume. J Pain 14:663–675CrossRef
2.
go back to reference May A (2008) Chronic pain may change the structure of the brain. Pain 137:7–15CrossRef May A (2008) Chronic pain may change the structure of the brain. Pain 137:7–15CrossRef
3.
go back to reference Baliki MN, Geha PY, Jabakhanji R, Harden N, Schnitzer TJ, Apkarian AV (2008) A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis. Mol Pain 4:47CrossRef Baliki MN, Geha PY, Jabakhanji R, Harden N, Schnitzer TJ, Apkarian AV (2008) A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis. Mol Pain 4:47CrossRef
5.
go back to reference Gwilym SE, Filippini N, Douaud G, Carr AJ, Tracey I (2010) Thalamic atrophy associated with painful osteoarthritis of the hip is reversible after arthroplasty: a longitudinal voxel-based morphometric study. Arthritis Rheum 62:2930–2940CrossRef Gwilym SE, Filippini N, Douaud G, Carr AJ, Tracey I (2010) Thalamic atrophy associated with painful osteoarthritis of the hip is reversible after arthroplasty: a longitudinal voxel-based morphometric study. Arthritis Rheum 62:2930–2940CrossRef
6.
go back to reference Rodriguez-Raecke R, Niemeier A, Ihle K, Ruether W, May A (2013) Structural brain changes in chronic pain reflect probably neither damage nor atrophy. PloS one 8(2):e54475CrossRef Rodriguez-Raecke R, Niemeier A, Ihle K, Ruether W, May A (2013) Structural brain changes in chronic pain reflect probably neither damage nor atrophy. PloS one 8(2):e54475CrossRef
7.
go back to reference Rodriguez-Raecke R, Niemeier A, Ihle K, Ruether W, May A (2009) Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. J Neurosci 29(44):13746–13750CrossRef Rodriguez-Raecke R, Niemeier A, Ihle K, Ruether W, May A (2009) Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. J Neurosci 29(44):13746–13750CrossRef
8.
go back to reference Mao CP, Bai ZL, Zhang XN, Zhang QJ, Zhang L (2016) Abnormal subcortical brain morphology in patients with knee osteoarthritis: a cross-sectional study. Front Aging Neurosci 8:3CrossRef Mao CP, Bai ZL, Zhang XN, Zhang QJ, Zhang L (2016) Abnormal subcortical brain morphology in patients with knee osteoarthritis: a cross-sectional study. Front Aging Neurosci 8:3CrossRef
9.
go back to reference Baliki MN, Schnitzer TJ, Bauer WR, Apkarian AV (2011) Brain morphological signatures for chronic pain. PLoS One 6(10):e26010CrossRef Baliki MN, Schnitzer TJ, Bauer WR, Apkarian AV (2011) Brain morphological signatures for chronic pain. PLoS One 6(10):e26010CrossRef
10.
go back to reference Sofat N, Harrison A, Russell MD, Ayis S, Kiely PD, Baker EH et al (2017) The effect of pregabalin or duloxetine on arthritis pain: a clinical and mechanistic study in people with hand osteoarthritis. J Pain Res 10:2437–2449CrossRef Sofat N, Harrison A, Russell MD, Ayis S, Kiely PD, Baker EH et al (2017) The effect of pregabalin or duloxetine on arthritis pain: a clinical and mechanistic study in people with hand osteoarthritis. J Pain Res 10:2437–2449CrossRef
11.
go back to reference Dworkin RH, Turk DC, Farrar JT et al (2005) Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113(1–2):9–19CrossRef Dworkin RH, Turk DC, Farrar JT et al (2005) Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113(1–2):9–19CrossRef
12.
go back to reference Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Li LC et al (2009) Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain 146:253–260CrossRef Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Li LC et al (2009) Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain 146:253–260CrossRef
14.
go back to reference Mechelli A, Price CJ, Friston KJ, Ashburner J (2005) Voxel-based morphometry of the human brain: methods and applications. Curr Med Imaging Rev 1:105–113CrossRef Mechelli A, Price CJ, Friston KJ, Ashburner J (2005) Voxel-based morphometry of the human brain: methods and applications. Curr Med Imaging Rev 1:105–113CrossRef
15.
16.
17.
go back to reference Peyron R, Laurent B, García-Larrea L (2000) Functional imaging of brain responses to pain. A review and meta-analysis (2000). Neurophysiol Clin 30:263–288CrossRef Peyron R, Laurent B, García-Larrea L (2000) Functional imaging of brain responses to pain. A review and meta-analysis (2000). Neurophysiol Clin 30:263–288CrossRef
18.
go back to reference Boccard SG, Pereira EA, Moir L, Van Hartevelt TJ, Kringelbach ML, FitzGerald JJ et al (2014) Deep brain stimulation of the anterior cingulate cortex: targeting the affective component of chronic pain. Neuroreport 25:83–88CrossRef Boccard SG, Pereira EA, Moir L, Van Hartevelt TJ, Kringelbach ML, FitzGerald JJ et al (2014) Deep brain stimulation of the anterior cingulate cortex: targeting the affective component of chronic pain. Neuroreport 25:83–88CrossRef
19.
go back to reference Bingel U, Lorenz J, Schoell E, Weiller C, Büchel C (2006) Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120:8–15CrossRef Bingel U, Lorenz J, Schoell E, Weiller C, Büchel C (2006) Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120:8–15CrossRef
20.
go back to reference Schrepf A, Harper DE, Harte SE, Wang H, Ichesco E, Hampson JP et al (2016) Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study. Pain 157:2217–2225CrossRef Schrepf A, Harper DE, Harte SE, Wang H, Ichesco E, Hampson JP et al (2016) Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study. Pain 157:2217–2225CrossRef
21.
go back to reference Kaygisiz B, Kilic FS, Senguleroglu N, Baydemir C, Erol K (2015) The antinociceptive effect and mechanisms of action of pregabalin in mice. Pharmacol Rep 67:129–133CrossRef Kaygisiz B, Kilic FS, Senguleroglu N, Baydemir C, Erol K (2015) The antinociceptive effect and mechanisms of action of pregabalin in mice. Pharmacol Rep 67:129–133CrossRef
Metadata
Title
Reduced anterior cingulate grey matter volume in painful hand osteoarthritis
Authors
Mark D. Russell
Thomas R. Barrick
Franklyn A. Howe
Nidhi Sofat
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 8/2018
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-018-4085-2

Other articles of this Issue 8/2018

Rheumatology International 8/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.